Hawthorn (Cratageus oxycantha)

Help for Heart & Circulation

Hawthorn is high in antioxidant flavonoids.(1-4)

Hawthorn extracts have been well researched and are widely used in Europe to treat many types of heart conditions including:

• atherosclerosis (3,5-6)
• hyperlipidemia (3,5-6,14)
• congestive heart failure (CHF) (3,7-12,14)
• high blood pressure (13-15)
• angina (16)

Hawthorn works by dilating (opening) coronary and peripheral blood vessels and improving oxygen utilization in the heart muscle.The proanthocyanidins (PCO's) in Hawthorn have been shown to lower cholesterol levels and decrease the size of cholesterol-containing plaques in the arteries.

Hawthorne Plus +

Suggested dose: 2 Capsules, 2 times per day.

Each one (1) Capsule contains:
Hawthorn flower & leaf extract (cratageus oxycantha) 100 mg
(standardized to 1.8% [1.8 mg] vitexin)
Garlic(Allium sativa) bulb powder 50 mg
Cayenne (Capsicum annum) fruit powder 50 mg

Product # 177 - Hawthorne Plus + (120 Caps) $15.95

Enter Quantity Desired and Click "Add To Cart" Button

REFERENCES

1.) Bahorun T, Gressier B, Trotin F, Brunet C, Dine T, Luyckx M, Vasseur J, Cazin M, Cazin JC, Pinkas M. Oxygen species scavenging activity of phenolic extracts from hawthorn fresh plant organs and pharmaceutical preparations. Arzneimittelforschung. 1996 Nov;46(11):1086-9.
2.) Bahorun T, Trotin F, Pommery J, et al. Antioxidant activities of Crataegus monogyna extracts. Planta Med 1994;60:323–8.
3.) Quettier-Deleu C, Voiselle G, Fruchart JC, Duriez P, Teissier E, Bailleul F, Vasseur J, Trotin F. Hawthorn extracts inhibit LDL oxidation. Pharmazie. 2003 Aug;58(8):577-81.
4.) Tadić VM, Dobrić S, Marković GM, Dordević SM, Arsić IA, Menković NR, Stević T. Anti-inflammatory, gastroprotective, free-radical-scavenging, and antimicrobial activities of hawthorn berries ethanol extract.J Agric Food Chem. 2008 Sep 10;56(17):7700-9. Epub 2008 Aug 13.
5.) Akila M, Devaraj H. Synergistic effect of tincture of Crataegus and Mangifera indica L. extract on hyperlipidemic and antioxidant status in atherogenic rats.Vascul Pharmacol. 2008 Oct-Dec;49(4-6):173-7. Epub 2008 Aug 8.
6.) Xu H, Xu HE, Ryan D. A study of the comparative effects of hawthorn fruit compound and simvastatin on lowering blood lipid levels. Am J Chin Med. 2009;37(5):903-8.
7. Weihmayr T, Ernst E. Therapeutic effectiveness of Crataegus. Fortschr Med 1996;114:27–9 [in German].
8. Schmidt U, Kuhn U, Ploch M, Hübner W-D. Efficacy of the Hawthorn (Crataegus) preparation LI 132 in 78 patients with chronic congestive heart failure defined as NYHA functional class II. Phytomed 1994;1:17–24.
9. Leuchtgens H. Crataegus special extract WS 1442 in heart failure, NYHA II. A placebo-controlled randomized double-blind study. Fortschr Med 1993;111:352–4.
10. Weikl A, Assmus KD, Neukum-Schmidt A, et al. Crataegus special extract WS 1442: Objective proof of efficacy in patients withy cardiac insufficiency (NYHA II). Fortschr Med 1996;114:291–6.
11. Rigelsky JM, Sweet BV. Hawthorn: pharmacology and therapeutic uses. Am J Health Syst Pharm. 2002 Mar 1;59(5):417-22.
12. Tauchert M, Ploch M, Hübner W-D. Effectiveness of hawthorn extract LI 132 compared with the ACE inhibitor Captopril: Multicenter double-blind study with 132 patients NYHA stage II. Münch Med Wochenschr 1994;132(suppl):S27–33.
13. Asgary S, Naderi GH, Sadeghi M, Kelishadi R, Amiri M. Antihypertensive effect of Iranian Crataegus curvisepala Lind.: a randomized, double-blind study. Drugs Exp Clin Res.
2004;30(5-6):221-5.
14. Chang WT, Dao J, Shao ZH. Hawthorn: potential roles in cardiovascular disease. Am J Chin Med. 2005;33(1):1-10.
15. Walker AF, Marakis G, Simpson E, Hope JL, Robinson PA, Hassanein M, Simpson HC. Hypotensive effects of hawthorn for patients with diabetes taking prescription drugs: a
randomised controlled trial. Br J Gen Pract. 2006 Jun;56(527):437-43.
16. Hanack T, Brückel M-H. The treatment of mild stable forms of angina pectoris using Crataegutt (R) Novo. Therapiewoche 1983;33:4331–3 [in German].